Edition:
United States

Grifols SA (GRFS.OQ)

GRFS.OQ on NASDAQ Stock Exchange Global Select Market

22.72USD
3:59pm EST
Change (% chg)

$-0.14 (-0.61%)
Prev Close
$22.86
Open
$22.75
Day's High
$22.86
Day's Low
$22.58
Volume
94,811
Avg. Vol
125,980
52-wk High
$25.17
52-wk Low
$17.18

Chart for

About

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 32.23 16.73
EPS (TTM): -- -- --
ROI: -- 14.02 35.60
ROE: -- 15.49 17.23

BRIEF-Grifols Receives FDA Approval For New Formulation Of Its Rabies Virus Treatment

* GRIFOLS HYPERRAB® (RABIES IMMUNE GLOBULIN) 300 IU/ML RECEIVES FDA APPROVAL TO TREAT PATIENTS EXPOSED TO RABIES VIRUS INFECTION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 06 2018

BRIEF-Grifols Sees Positive Impact Of 90 Mln Euros In Q4 After Revaluation Of US Assets

* SEES POSITIVE NON-RECURRING IMPACT OF ABOUT 90 MILLION EUROS NET IN Q4 FROM US TAX REFORM AND REASSESSMENT OF ASSETS RELATED TO ARADIGM Source text for Eikon:

Jan 30 2018

BRIEF-Grifols Buys 51 Pct Of Medkeeper

* SAYS PURCHASE RESULT OF $98 MLN CAPITAL INCREASE IN MEDKEEPER

Jan 26 2018

BRIEF-Grifols Gets Loan With EIB For 85 Mln Euros

* GETS LONG-TERM LOAN WITH THE EUROPEAN INVESTMENT BANK (EIB) FOR 85 MILLION EUROS

Dec 05 2017

BRIEF-Grifols gets approval from US FDA for new product

* EARNS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR NEW PRODUCT FIBRIN SEALANT (HUMAN) COMPOSED OF TWO PLASMA PROTEINS AND INDICATED FOR SURGICAL USE IN ADULTS ‍​ Source text for Eikon:

Nov 06 2017

BRIEF-Grifols 9-month net profit up 6.3 pct at 431.8 mln euros YoY

* 9-MONTH NET PROFIT 431.8 MILLION EUROS VERSUS 406.1 MILLION EUROS YEAR AGO

Nov 02 2017

BRIEF-Grifols approves interim dividend of 0.18 eur/shr

* APPROVES INTERIM DIVIDEND OF 0.18 EURO PER SHARE PAYABLE DECEMBER 5‍​ Source text for Eikon:

Oct 30 2017

Henkel buys Shiseido's U.S. professional hair unit for $485 million

FRANKFURT German consumer goods maker Henkel has agreed to buy Zotos International from Japan's Shiseido Company for $485 million to further grow its footprint in the U.S. professional hair-care sector.

Oct 27 2017

Henkel buys Shiseido's U.S. professional hair unit for $485 mln

FRANKFURT, Oct 27 German consumer goods maker Henkel has agreed to buy Zotos International from Japan's Shiseido Company for $485 million to further grow its footprint in the U.S. professional hair-care sector.

Oct 27 2017

Spain's Grifols to remain in Catalonia for now -source

MADRID, Oct 9 Spain's Grifols has no plans to leave Catalonia at the moment but, if the current situation changes in a way which could affect the company's business, the board will take appropriate steps, a company sources said on Monday. (Reporting by Emma Pinedo; Writing by Paul Day; Editing by Jesus Aguado)

Oct 09 2017

Earnings vs. Estimates